Teladoc Inc. (TDOC)
NYSE:TDOC
Want to see TDOC full AI Analyst Report?
TDOC Stock Chart & Stats
$5.69
-$0.30(-3.00%)
At close: 4:00 PM EST
$5.69
-$0.30(-3.00%)
Day’s Range― - ―
52-Week Range$4.40 - $9.77
Previous CloseN/A
Volume1.13M
Average Volume (3M)5.20M
Market Cap
$1.36B
Enterprise Value$1.65B
Total Cash (Recent Filing)$750.74M
Total Debt (Recent Filing)$1.03B
Price to Earnings (P/E)―
Beta1.55
Next Earnings
Jul 28, 2026EPS Estimate
-0.25Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.97
Shares Outstanding180,513,090
10 Day Avg. Volume4,399,232
30 Day Avg. Volume5,198,647
Financial Highlights & Ratios
PEG Ratio0.08
Price to Book (P/B)0.89
Price to Sales (P/S)0.49
P/FCF Ratio4.32
Enterprise Value/Market Cap1.21
Enterprise Value/Revenue0.66
Enterprise Value/Gross Profit1.00
Enterprise Value/Ebitda25.77
Forecast
1Y Price Target
$7.50Price Target Upside31.81% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering18
EPS Forecast (FY)-0.91
Revenue Forecast (FY)$2.51B
Bulls Say, Bears Say
Bulls Say
Strong Free Cash Flow GenerationConsistent positive operating and free cash flow despite net losses provides durable financial flexibility. It funds operations, product investment and debt reduction without relying solely on equity; supports execution of insurance rollout and AI efficiency initiatives over the next 2–6 months.
Large Integrated Care Membership And Chronic Care TractionA >100M membership base and growing chronic care enrollment create recurring, contractually distributed revenue and higher lifetime value. Scale in Integrated Care supports margin expansion, cross-selling of programs and stable utilization trends that underpin multi-quarter revenue resilience.
BetterHelp Insurance Rollout MomentumTransitioning BetterHelp toward insurance reimbursement is a structural revenue mix shift: broader contracted lives, higher session rates and insurance-covered users' greater engagement can improve long‑term revenue quality and margins as insurance penetration scales.
Bears Say
BetterHelp User And Revenue DeclinesSustained declines in paying users and cash-pay revenue indicate underlying demand weakness and create a multi-quarter drag on topline. Recovery depends on successful insurance conversion and provider participation; until then mix and utilization trends may suppress margins.
Ongoing Negative ProfitabilityPersisting negative operating and net margins constrain reinvestment and returns. Even with improving cash flow, structural profitability must improve to sustain long-term growth investments; otherwise the company risks slower scale or continued reliance on cash reserves.
Elevated Gross Debt And Convertible Note RiskMaterial gross leverage and a near‑term convertible maturity introduce refinancing and capital‑structure uncertainty. Failure to execute planned deleveraging could increase interest costs, constrain strategic flexibility or force dilutive actions, affecting multi‑quarter execution risk.
Teladoc News
TDOC FAQ
What was Teladoc Inc.’s price range in the past 12 months?
Teladoc Inc. lowest stock price was $4.40 and its highest was $9.77 in the past 12 months.
What is Teladoc Inc.’s market cap?
Teladoc Inc.’s market cap is $1.36B.
When is Teladoc Inc.’s upcoming earnings report date?
Teladoc Inc.’s upcoming earnings report date is Jul 28, 2026 which is in 55 days.
How were Teladoc Inc.’s earnings last quarter?
Teladoc Inc. released its earnings results on Apr 29, 2026. The company reported -$0.36 earnings per share for the quarter, missing the consensus estimate of -$0.341 by -$0.019.
Is Teladoc Inc. overvalued?
According to Wall Street analysts Teladoc Inc.’s price is currently Undervalued.
Does Teladoc Inc. pay dividends?
Teladoc Inc. does not currently pay dividends.
What is Teladoc Inc.’s EPS estimate?
Teladoc Inc.’s EPS estimate is -0.25.
How many shares outstanding does Teladoc Inc. have?
Teladoc Inc. has 180,513,090 shares outstanding.
What happened to Teladoc Inc.’s price movement after its last earnings report?
Teladoc Inc. reported an EPS of -$0.36 in its last earnings report, missing expectations of -$0.341. Following the earnings report the stock price went up 1.849%.
Which hedge fund is a major shareholder of Teladoc Inc.?
Currently, no hedge funds are holding shares in TDOC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Teladoc Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$7.50 (31.81% Upside)
$7.50 (31.81% Upside)
Blogger Sentiment
Bullish
TDOC Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 689.6K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▲ 0.4%
Last 30 Days ▼ 2.9%
Last 30 Days ▼ 2.9%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
14.30%
12-Months-Change
Fundamentals
Return on Equity
-12.37%
Trailing 12-Months
Asset Growth
-18.50%
Trailing 12-Months
Company Description
Teladoc Inc.
Teladoc Health, Inc. provides virtual healthcare services in the United States and internationally. The company offers a portfolio of services and solutions covering non-urgent, episodic, chronic, and complicated medical conditions, including diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and mental health conditions. It offers a range of programs and services, including primary and specialty care telehealth solutions, chronic condition management, expert medical services, mental health solutions, and platform and program services. The company serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. It offers its products and services under the Teladoc, Livongo, and BetterHelp brands. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. The company was incorporated in 2002 and is headquartered in Purchase, New York.
TDOC Company Deck
TDOC Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call balanced clear progress on strategic priorities—Integrated Care growth and margin improvement, meaningful BetterHelp insurance momentum, AI-driven efficiency gains, and affirmed full-year guidance—against notable near-term challenges including a weakening BetterHelp cash-pay business, margin pressure, implementation timing shifts, free cash flow seasonality and lingering gross debt/convertible note risk. Execution on the insurance rollout and the transition from subscription to visit-based models are key catalysts that underpin upside; therapist capacity and near-term mix effects are the main risks to monitor.View all TDOC earnings summariesTDOC Revenue Breakdown
56.44% Teladoc Health Integrated Care
43.56% BetterHelp
TDOC Stock 12 Month Forecast
Average Price Target
$7.50
▲(31.81% Upside)
Technical Analysis
Ownership Overview
0.58% Insiders
22.33% Mutual Funds
14.59% Other Institutional Investors
43.42% Public Companies and Individual Investors